Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Eikon Therapeutics Appoints Ching Pin Chang As Chief Scientific Officer
PUBLIC · EIKNSep 03, 2026•4 days ago
Position
Executive Vice President
Company
Eikon Therapeutics
HaywardBiotechnologyHealth CareTherapeuticsDescription
Eikon Therapeutics has announced the appointment of Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer. Dr
Don't miss Eikon Therapeutics's next move
Get an email the moment Eikon Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months
Eikon Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.